位置:首页 > 蛋白库 > MATRX_SENDH
MATRX_SENDH
ID   MATRX_SENDH             Reviewed;         348 AA.
AC   P03426;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   21-JUL-1986, sequence version 1.
DT   29-SEP-2021, entry version 85.
DE   RecName: Full=Matrix protein;
DE            Short=M protein;
GN   Name=M;
OS   Sendai virus (strain Harris) (SeV).
OC   Viruses; Riboviria; Orthornavirae; Negarnaviricota; Haploviricotina;
OC   Monjiviricetes; Mononegavirales; Paramyxoviridae; Orthoparamyxovirinae;
OC   Respirovirus.
OX   NCBI_TaxID=11196;
OH   NCBI_TaxID=10144; Cavia cutleri (Guinea pig).
OH   NCBI_TaxID=36483; Cricetidae sp. (Hamster).
OH   NCBI_TaxID=10090; Mus musculus (Mouse).
OH   NCBI_TaxID=10116; Rattus norvegicus (Rat).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RX   PubMed=6092688; DOI=10.1128/jvi.52.2.656-663.1984;
RA   Blumberg B.M., Rose K., Simona M.G., Roux L., Giorgi C., Kolakofsky D.;
RT   "Analysis of the Sendai virus M gene and protein.";
RL   J. Virol. 52:656-663(1984).
RN   [2]
RP   SUBCELLULAR LOCATION, AND MUTAGENESIS OF 112-THR-VAL-113.
RX   PubMed=8661424; DOI=10.1006/viro.1996.0362;
RA   Mottet G., Muehlemann A., Tapparel C., Hoffmann F., Roux L.;
RT   "A Sendai virus vector leading to the efficient expression of mutant M
RT   proteins interfering with virus particle budding.";
RL   Virology 221:159-171(1996).
RN   [3]
RP   INTERACTION WITH MEMBRANE, AND MUTAGENESIS OF THR-112; VAL-113 AND
RP   112-THR-VAL-113.
RX   PubMed=10580060; DOI=10.1099/0022-1317-80-11-2977;
RA   Mottet G., Mueller V., Roux L.;
RT   "Characterization of Sendai virus M protein mutants that can partially
RT   interfere with virus particle production.";
RL   J. Gen. Virol. 80:2977-2986(1999).
CC   -!- FUNCTION: Acts as a negative regulator for transcription and
CC       replication by sticking to the nucleocapsid. This effect might be
CC       regulated by the cytoplasmic interaction with tubulin that dissociates
CC       the M protein from the nucleocapsid (By similarity). Plays a crucial
CC       role in virion assembly and budding. Forms a shell at the inner face of
CC       the plasma membrane and concentrates the HN and F glycoproteins.
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Homomultimer. Binds to the cytoplasmic regions of F and HN
CC       proteins. Interacts with nucleocapsid. Interacts with human alpha-
CC       tubulin and beta-tubulin. Interacts with host ANP32B.
CC       {ECO:0000250|UniProtKB:P06446}.
CC   -!- SUBCELLULAR LOCATION: Virion {ECO:0000305}. Host cytoplasm
CC       {ECO:0000269|PubMed:8661424}. Host cell membrane
CC       {ECO:0000269|PubMed:8661424}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:8661424}; Cytoplasmic side
CC       {ECO:0000269|PubMed:8661424}. Note=During bud formation, associates at
CC       the inner side of the plasma membrane of infected cells.
CC   -!- DOMAIN: Late-budding domains (L domains) are short sequence motifs
CC       essential for viral particle budding. They recruit proteins of the host
CC       ESCRT machinery (Endosomal Sorting Complex Required for Transport) or
CC       ESCRT-associated proteins. The matrix protein contains one L domain: a
CC       YLDL motif (By similarity). {ECO:0000250}.
CC   -!- PTM: A large portion is phosphorylated in the cytoplasm, but not in
CC       virion. However, this phosphorylation is not essential for virus
CC       replication (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the morbillivirus/respirovirus/rubulavirus M
CC       protein family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; K02742; AAA47811.1; -; Genomic_RNA.
DR   PIR; A04042; MFNZS.
DR   SMR; P03426; -.
DR   GO; GO:0030430; C:host cell cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0020002; C:host cell plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-KW.
DR   GO; GO:0039660; F:structural constituent of virion; IEA:UniProtKB-KW.
DR   GO; GO:0039702; P:viral budding via host ESCRT complex; IEA:UniProtKB-KW.
DR   Gene3D; 2.70.20.50; -; 1.
DR   Gene3D; 2.70.20.60; -; 1.
DR   InterPro; IPR000982; Matrix.
DR   InterPro; IPR042539; Matrix_C.
DR   InterPro; IPR042540; Matrix_N.
DR   Pfam; PF00661; Matrix; 1.
PE   1: Evidence at protein level;
KW   Host cell membrane; Host cytoplasm; Host membrane; Host-virus interaction;
KW   Membrane; Phosphoprotein; Viral budding;
KW   Viral budding via the host ESCRT complexes; Viral matrix protein;
KW   Viral release from host cell; Virion.
FT   CHAIN           1..348
FT                   /note="Matrix protein"
FT                   /id="PRO_0000142774"
FT   MOTIF           50..53
FT                   /note="YLDL motif"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         70
FT                   /note="Phosphoserine; by host"
FT                   /evidence="ECO:0000250"
FT   MUTAGEN         112..113
FT                   /note="TV->EE,KE: Not incorporated in virions. No effect on
FT                   in vitro membrane association."
FT                   /evidence="ECO:0000269|PubMed:10580060"
FT   MUTAGEN         112..113
FT                   /note="TV->KR,ME: Not incorporated in virions. Loss of
FT                   efficient in vivo transport to the plasma membrane. 60%
FT                   loss of in vitro membrane association. Reduces
FT                   nucleocapsid-membrane association. Loss of interaction with
FT                   itself."
FT                   /evidence="ECO:0000269|PubMed:10580060"
FT   MUTAGEN         112..113
FT                   /note="TV->RE: Not incorporated in virions."
FT                   /evidence="ECO:0000269|PubMed:10580060,
FT                   ECO:0000269|PubMed:8661424"
FT   MUTAGEN         112
FT                   /note="T->E,M: No effect."
FT                   /evidence="ECO:0000269|PubMed:10580060"
FT   MUTAGEN         112
FT                   /note="T->K,R: 20% increase of in vitro membrane
FT                   association."
FT                   /evidence="ECO:0000269|PubMed:10580060"
FT   MUTAGEN         113
FT                   /note="V->A: Not incorporated in virions."
FT                   /evidence="ECO:0000269|PubMed:10580060"
FT   MUTAGEN         113
FT                   /note="V->C: No effect."
FT                   /evidence="ECO:0000269|PubMed:10580060"
FT   MUTAGEN         113
FT                   /note="V->E: Not incorporated in virions. 50% loss of in
FT                   vitro membrane association."
FT                   /evidence="ECO:0000269|PubMed:10580060"
FT   MUTAGEN         113
FT                   /note="V->F,K,L,R: Not incorporated in virions."
FT                   /evidence="ECO:0000269|PubMed:10580060"
SQ   SEQUENCE   348 AA;  38590 MW;  C1C0133694F16F88 CRC64;
     MADIYRFPKF SYEDNGTVEP LPLRTGSDKK AIPYIRIIKV GDPPKHGVRY LDLLLLGFFE
     TPKQTTNLGS VSDLTEPTSY SICGSGSLPI GVAKYYGTDQ ELLKACTDLR ITVRRTVRAG
     EMIVYMVDSI GAPLLPWSGR LRQGMIFNAN KVALAPQCLP VDKDIRFRVV FVNGTSLGAI
     TIAKIPKTLA DLALPNSISV NLLVTLKTGI STEQKGVLPV LDDQGEKKLN FMVHLGLIRR
     KVGKIYSVEY CKSKIERMRL IFSLGLIGGI SFHVQVTGTL SKTFMSQLAW KRAVCFPLMD
     VNPHMNLVIW AASVEITGVD AVFQPAIPRD FRYYPNVVAK NIGRIRKL
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024